Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits

利用 CRISPR 干扰技术使耻垢分枝杆菌重新对利福平敏感，证明了其在研究非必需耐药性状方面的实用性。